• Consensus Rating: Buy
  • Consensus Price Target: $23.42
  • Forecasted Upside: 85.73 %
  • Number of Analysts: 17
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 11 Buy Ratings
  • 0 Strong Buy Ratings
$12.61
▲ +0.04 (0.32%)

This chart shows the closing price for PATH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New UiPath Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PATH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PATH

Analyst Price Target is $23.42
▲ +85.73% Upside Potential
This price target is based on 17 analysts offering 12 month price targets for UiPath in the last 3 months. The average price target is $23.42, with a high forecast of $64.00 and a low forecast of $14.00. The average price target represents a 85.73% upside from the last price of $12.61.

This chart shows the closing price for PATH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 17 contributing investment analysts is to buy stock in UiPath. This rating has held steady since July 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 11 buy ratings
  • 6 hold ratings
  • 2 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 12 buy ratings
  • 6 hold ratings
  • 2 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 12 buy ratings
  • 7 hold ratings
  • 2 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 2 sell ratings
7/4/2022
  • 0 strong buy ratings
  • 10 buy ratings
  • 5 hold ratings
  • 0 sell ratings
9/2/2022
  • 0 strong buy ratings
  • 11 buy ratings
  • 6 hold ratings
  • 0 sell ratings
10/2/2022

Latest Recommendations

  • 0 strong buy ratings
  • 11 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
9/30/2022Canaccord Genuity GroupLower Target$15.00 ➝ $14.00Low
9/30/2022Wells Fargo & CompanyLower Target$22.00 ➝ $16.00Low
9/28/2022Bank of AmericaLower Target$20.00 ➝ $18.00Low
9/28/2022Credit Suisse GroupLower TargetOutperform$37.50 ➝ $30.00Low
9/28/2022BarclaysLower TargetOverweight$18.00 ➝ $17.00Low
9/7/2022Canaccord Genuity GroupReiterated RatingBuy ➝ Hold$25.00 ➝ $15.00Low
9/7/2022Canaccord Genuity GroupDowngradeBuy ➝ Hold$25.00 ➝ $15.00Low
9/7/2022CowenLower TargetOutperform$27.00 ➝ $20.00Low
9/7/2022Truist FinancialLower TargetBuy$45.00 ➝ $25.00Low
9/7/2022BMO Capital MarketsLower Target$21.00 ➝ $15.00Low
9/7/2022Royal Bank of CanadaLower Target$22.00 ➝ $18.00Low
9/7/2022Needham & Company LLCLower TargetBuy$40.00 ➝ $20.00Low
9/7/2022CowenLower Target$27.00 ➝ $20.00Low
9/7/2022Wells Fargo & CompanyLower TargetOverweight$30.00 ➝ $22.00Low
9/7/2022Credit Suisse GroupLower TargetOutperform$45.00 ➝ $37.50Low
9/7/2022MizuhoDowngradeBuy ➝ Neutral$40.00 ➝ $14.00Low
9/7/2022Morgan StanleyDowngradeOverweight ➝ Equal Weight$32.00 ➝ $15.00Low
7/7/2022Canaccord Genuity GroupReiterated RatingBuy$25.00N/A
6/2/2022BMO Capital MarketsLower Target$29.00 ➝ $21.00Low
6/2/2022Truist FinancialLower Target$55.00 ➝ $45.00High
6/2/2022Evercore ISILower Target$28.00 ➝ $23.00High
6/2/2022Credit Suisse GroupLower Target$57.50 ➝ $45.00High
6/2/2022OppenheimerLower TargetBuy$35.00 ➝ $23.00High
5/31/2022Royal Bank of CanadaLower Target$32.00 ➝ $27.00High
5/27/2022CowenLower Target$43.00 ➝ $27.00Medium
5/20/2022BarclaysLower Target$36.00 ➝ $25.00Medium
5/18/2022Wells Fargo & CompanyLower Target$35.00 ➝ $30.00Medium
4/25/2022KeyCorpLower TargetOverweight$34.00 ➝ $23.00High
3/31/2022Morgan StanleyLower TargetOverweight$74.00 ➝ $41.00High
3/31/2022Canaccord Genuity GroupLower TargetHold$55.00 ➝ $30.00High
3/31/2022Truist FinancialLower TargetBuy$75.00 ➝ $55.00High
3/31/2022Canaccord Genuity GroupLower Target$55.00 ➝ $30.00High
3/31/2022Needham & Company LLCLower TargetBuy$85.00 ➝ $40.00High
3/31/2022CowenLower Target$72.00 ➝ $43.00High
3/31/2022BMO Capital MarketsLower TargetMarket Perform$52.00 ➝ $29.00High
3/31/2022MizuhoLower TargetBuy$70.00 ➝ $40.00High
3/31/2022Credit Suisse GroupLower TargetOutperform$75.00 ➝ $57.50High
3/31/2022OppenheimerLower TargetOutperform$56.00 ➝ $35.00High
3/31/2022Wells Fargo & CompanyLower TargetOverweight$45.00 ➝ $35.00High
3/29/2022Evercore ISILower Target$57.00 ➝ $36.00High
3/28/2022Royal Bank of CanadaLower TargetSector Perform$47.00 ➝ $37.00High
3/15/2022Wells Fargo & CompanyLower TargetOverweight$60.00 ➝ $45.00Low
1/25/2022MacquarieUpgradeNeutral ➝ OutperformLow
1/20/2022OppenheimerUpgradeMarket Perform ➝ Outperform$56.00High
1/12/2022BarclaysLower Target$61.00 ➝ $57.00High
1/6/2022Wells Fargo & CompanyUpgradeEqual Weight ➝ Overweight$60.00High
12/9/2021Truist FinancialLower TargetBuy ➝ Buy$82.00 ➝ $75.00Low
12/9/2021KeyCorpLower TargetOverweight ➝ Overweight$86.00 ➝ $69.00Low
12/9/2021BarclaysLower TargetOverweight$71.00 ➝ $61.00Low
12/9/2021Wells Fargo & CompanyLower TargetEqual Weight ➝ Equal Weight$65.00 ➝ $50.00Low
12/9/2021MacquarieReiterated RatingNeutral$71.00 ➝ $55.00Medium
12/9/2021Berenberg BankUpgradeHold ➝ Buy$64.00Low
12/3/2021Morgan StanleyUpgradeEqual Weight ➝ Overweight$74.00High
12/1/2021BMO Capital MarketsLower TargetPositive ➝ Market Perform$70.00 ➝ $57.00High
11/16/2021Credit Suisse GroupInitiated CoverageOutperform$75.00High
10/8/2021CowenLower TargetOutperform$80.00 ➝ $72.00Medium
10/7/2021Royal Bank of CanadaLower TargetSector Perform$74.00 ➝ $65.00Low
10/6/2021Needham & Company LLCReiterated RatingBuy$85.00Low
9/17/2021BarclaysUpgradeEqual Weight ➝ Overweight$70.00 ➝ $71.00High
9/8/2021BarclaysLower TargetEqual Weight$73.00 ➝ $70.00Low
9/8/2021BMO Capital MarketsLower TargetMarket Perform$85.00 ➝ $70.00High
9/8/2021Morgan StanleyBoost TargetEqual Weight$72.00 ➝ $74.00High
9/8/2021CowenLower TargetOutperform$84.00 ➝ $80.00High
9/8/2021Wells Fargo & CompanyLower TargetEqual Weight$75.00 ➝ $65.00High
9/8/2021OppenheimerReiterated RatingHoldHigh
7/12/2021Summit RedstoneInitiated CoverageSell$40.00Low
7/12/2021Summit InsightsInitiated CoverageSell$40.00Medium
6/10/2021Evercore ISIReiterated RatingHold$72.00High
6/9/2021BMO Capital MarketsBoost TargetMarket Perform$80.00 ➝ $85.00High
6/9/2021Truist FinancialBoost TargetBuy$80.00 ➝ $82.00Medium
6/9/2021KeyCorpBoost TargetOverweight$82.00 ➝ $86.00High
6/9/2021Morgan StanleyBoost TargetEqual Weight$70.00 ➝ $72.00High
6/9/2021Needham & Company LLCReiterated RatingBuy$85.00High
6/9/2021BarclaysBoost TargetEqual Weight$71.00 ➝ $73.00High
5/24/2021OppenheimerInitiated CoverageMarket PerformHigh
5/19/2021Berenberg BankInitiated CoverageHold$64.00Low
5/17/2021Truist FinancialInitiated CoverageBuy$80.00N/A
5/17/2021MacquarieInitiated CoverageNeutral$69.00N/A
5/17/2021Wolfe ResearchInitiated CoveragePeer Perform$70.00N/A
5/17/2021DA DavidsonInitiated CoverageBuy$85.00N/A
5/17/2021Wells Fargo & CompanyInitiated CoverageEqual Weight$75.00N/A
5/17/2021MizuhoInitiated CoverageBuy$77.00N/A
5/17/2021Needham & Company LLCInitiated CoverageBuy$85.00N/A
5/17/2021CowenInitiated CoverageOutperform$82.00N/A
5/17/2021Morgan StanleyInitiated CoverageEqual Weight$70.00N/A
5/17/2021Royal Bank of CanadaInitiated CoverageSector Perform$74.00N/A
5/17/2021Bank of AmericaInitiated CoverageBuy$85.00N/A
5/17/2021JPMorgan Chase & Co.Initiated CoverageNeutral$68.00N/A
5/17/2021BMO Capital MarketsInitiated CoverageMarket Perform$80.00N/A
5/17/2021BarclaysInitiated CoverageEqual Weight$71.00N/A
5/17/2021KeyCorpInitiated CoverageOverweight$82.00N/A
5/17/2021Evercore ISIInitiated CoverageIn-Line$72.00N/A
5/17/2021OppenheimerReiterated RatingMarket PerformN/A
5/13/2021Berenberg BankInitiated CoverageHold$64.00N/A
(Data available from 10/2/2017 forward)

News Sentiment Rating

0.16 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 2 very positive mentions
  • 19 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
3/6/2022
  • 12 very positive mentions
  • 42 positive mentions
  • 7 negative mentions
  • 1 very negative mentions
4/5/2022
  • 6 very positive mentions
  • 21 positive mentions
  • 4 negative mentions
  • 5 very negative mentions
5/5/2022
  • 9 very positive mentions
  • 29 positive mentions
  • 6 negative mentions
  • 0 very negative mentions
6/4/2022
  • 5 very positive mentions
  • 17 positive mentions
  • 5 negative mentions
  • 0 very negative mentions
7/4/2022
  • 5 very positive mentions
  • 15 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
8/3/2022
  • 3 very positive mentions
  • 21 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
9/2/2022
  • 15 very positive mentions
  • 51 positive mentions
  • 21 negative mentions
  • 4 very negative mentions
10/2/2022

Current Sentiment

  • 15 very positive mentions
  • 51 positive mentions
  • 21 negative mentions
  • 4 very negative mentions

Recent Stories by Sentiment

UiPath logo
UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, and Japan. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform combines artificial intelligence with desktop recording, back-end mining of both human activity and system logs, and intuitive visualization tools, which enables users to discover, analyze, and identify processes to automate in a centralized portal; offers low-code development environments that allows users in an organization to create attended and unattended automations without any prior knowledge of coding; deploys robots in highly immersive attended experiences or in standalone, unattended modes behind the scenes, and can leverage native connectors built for commonly used line-of-business applications; offers centralized tools designed to manage, test, and deploy automations and ML models across the enterprise; allows customers to manage long running processes that orchestrate work between robots and humans; and enable users to track, measure, and forecast the performance of automation in their enterprise and help businesses ensure compliance with business standards. In addition, the company provides maintenance and support for its software, as well as professional services, such as training and implementation services to facilitate the adoption of its platform. It serves banking, healthcare, financial services, and government entities. UiPath Inc. was founded in 2005 and is headquartered in New York, New York.
Read More

Today's Range

Now: $12.61
Low: $12.41
High: $13.02

50 Day Range

MA: $16.86
Low: $12.57
High: $21.94

52 Week Range

Now: $12.61
Low: $12.12
High: $59.57

Volume

9,803,083 shs

Average Volume

10,675,820 shs

Market Capitalization

$6.87 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.11

Frequently Asked Questions

What sell-side analysts currently cover shares of UiPath?

The following Wall Street sell-side analysts have issued research reports on UiPath in the last twelve months: Bank of America Co., Barclays PLC, Berenberg Bank, BMO Capital Markets, Canaccord Genuity Group Inc., Cleveland Research, Cowen Inc, Cowen Inc., Credit Suisse Group AG, Evercore ISI, KeyCorp, Macquarie, Mizuho, Morgan Stanley, Needham & Company LLC, Oppenheimer Holdings Inc., Royal Bank of Canada, Truist Financial Co., and Wells Fargo & Company.
View the latest analyst ratings for PATH.

What is the current price target for UiPath?

19 Wall Street analysts have set twelve-month price targets for UiPath in the last year. Their average twelve-month price target is $23.42, suggesting a possible upside of 85.7%. Berenberg Bank has the highest price target set, predicting PATH will reach $64.00 in the next twelve months. Mizuho has the lowest price target set, forecasting a price of $14.00 for UiPath in the next year.
View the latest price targets for PATH.

What is the current consensus analyst rating for UiPath?

UiPath currently has 6 hold ratings and 11 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe PATH will outperform the market and that investors should add to their positions of UiPath.
View the latest ratings for PATH.

What other companies compete with UiPath?

How do I contact UiPath's investor relations team?

UiPath's physical mailing address is 7 Great Valley Pkwy Ste 300, MALVERN, PA 19355-1425, United States. The healthcare company's listed phone number is 844-432-0455 and its investor relations email address is [email protected] The official website for UiPath is www.nupathe.com. Learn More about contacing UiPath investor relations.